Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Backlog for Engineering Construction (USD Mil) refers to the quantity and money amount of the product which has been ordered by customers but which has not shipped yet for engineering construction.
Enovis's Backlog for Engineering Construction (USD Mil) for the quarter that ended in Mar. 2019 was 893.00
, which higher from pervious quarter (Dec. 2018)'s result by 7.31%.
Enovis's Backlog for Engineering Construction (USD Mil) for the annual that ended in Dec. 2018 was 832.20
, which lower from pervious year (Dec. 2017)'s result by 6.85%.
The historical rank and industry rank for Enovis's Backlog for Engineering Construction (USD Mil) or its related term are showing as below:
ENOV's Backlog for Engineering Construction (USD Mil) is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: * Ranked among companies with meaningful Backlog for Engineering Construction (USD Mil) only.
Enovis's New Orders (USD Mil) for the quarter that ended in Mar. 2019 was 384.30
, which lower from pervious quarter (Dec. 2018)'s result by 6.68%.
Enovis's New Orders (USD Mil) for the annual that ended in Dec. 2018 was 1,436.40
, which higher from pervious year (Dec. 2017)'s result by 9.94%.
Enovis (NYSE:ENOV) Backlog for Engineering Construction (USD Mil) Explanation
Backlog refers to the quantity and money amount of the product which has been ordered by customers but which has not shipped yet. Each backlog includes the following information: job order number, product number, delivery date, quantity, the order status (i.e. showing that it is now being assembled, or when delivery is being planned).
The backlog reflects the company’s inventory management processing level. We usually consider a low backlog number to be a sign of good inventory management. If the backlog is too big, it can lead to customer frustration and canceled orders. A healthy backlog shows that the product or service of the company is in-demand and seeing steady growth.
Enovis Backlog for Engineering Construction (USD Mil) Historical Data
* Premium members only.
The historical data trend for Enovis's Backlog for Engineering Construction (USD Mil) can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enovis Backlog for Engineering Construction (USD Mil) Chart
ENOV vs IART, AHCO, INSP: Backlog for Engineering Construction (USD Mil) Comparison
For the Medical Devices subindustry, Enovis's Backlog for Engineering Construction (USD Mil), along with its competitors' market caps and Backlog for Engineering Construction (USD Mil) data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
What does a Backlog for Engineering Construction (USD Mil) of 893.00 mean?
Enovis (ENOV) has a Backlog for Engineering Construction (USD Mil) of 893.00 as of Mar. 2019.
Is Enovis' Backlog for Engineering Construction (USD Mil) too high?
Enovis' current Backlog for Engineering Construction (USD Mil) is 893.00. Overall, Enovis has a GF Score™ of 66/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Enovis' Backlog for Engineering Construction (USD Mil) compare to IART and AHCO?
Enovis' Backlog for Engineering Construction (USD Mil) of 893.00 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Backlog for Engineering Construction (USD Mil) for a Medical Devices & Instruments company?
A good Backlog for Engineering Construction (USD Mil) depends on the Medical Devices & Instruments industry context. However, Backlog for Engineering Construction (USD Mil) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Backlog for Engineering Construction (USD Mil) mean?
A high Backlog for Engineering Construction (USD Mil) can signal that a stock is expensive relative to its fundamentals. Enovis's current Backlog for Engineering Construction (USD Mil) is 893.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Enovis stock overvalued right now?
Based on GuruFocus' analysis, Enovis (ENOV) is currently considered Possible Value Trap. The stock's GF Value™ is $50.25, compared to a current price of $29.15 — trading 42% below its estimated fair value. The current Backlog for Engineering Construction (USD Mil) is 893.00. Enovis' overall GF Score™ is 66/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Backlog for Engineering Construction (USD Mil) calculated?
Backlog for Engineering Construction (USD Mil) is calculated from a company's financial statements. For Enovis (ENOV), the current Backlog for Engineering Construction (USD Mil) is 893.00 as of Mar. 2019. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Enovis (ENOV) Overvalued in 2026?
Based on GuruFocus' analysis, Enovis stock appears to be undervalued.
The current stock price of $29.15 is trading 42% below its estimated GF Value™ of $50.25.
GuruFocus considers Enovis to be Possible Value Trap.
Key valuation signals for ENOV:
Backlog for Engineering Construction (USD Mil): 893.00
GF Value™: $50.25 vs. price of $29.15 (42% below fair value)
No single metric tells the full story. See the ENOV stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Enovis Corp is a medical technology manufacturer and distributor of medical devices used in reconstructive surgery, rehabilitation, pain management, and physical therapy. Its products support patient care from injury prevention through post-surgical or post-injury rehabilitation and treatment of degenerative conditions. The company's reportable segments include Prevention & Recovery and Reconstructive segments. The majority of revenueis derived from the Prevention & Recovery segment, which includes products that are used by orthopedic specialists, primary care physicians, physical therapists, chiropractors, athletic trainers and other healthcare professionals to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformitiesand sports-related injuries.
66GF Score
Get the complete analysis for ENOV
Backlog for Engineering Construction (USD Mil) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ENOV has been successfully added to your 
